Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 15/20 | 0.60 |
| ▸ | HSD17B2 | P37059 | 15/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.57 |
| ▸ | IKBKB | O14920 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2690201 | 0.79 | IKBKB (0.68) | EPHX2IKBKBHPGDS | |
| SCHEMBL6612574 | 0.78 | HPGDS (0.60) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL1784584 | 0.78 | HPGDS (0.73) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL29922717 | 0.77 | EPHX2 (0.58) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL27565420 | 0.77 | ESRRG (0.59) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL27565581 | 0.77 | IKBKB (0.71) | HSD17B1HSD17B2EPHX2IKBKBCNR1 | |
| SCHEMBL28541614 | 0.77 | EPHX2 (0.58) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL27816573 | 0.77 | EPHX2 (0.52) | HSD17B1HSD17B2EPHX2IKBKBHPGDS | |
| SCHEMBL5613367 | 0.77 | HDAC6 (0.71) | HSD17B1HSD17B2EPHX2IKBKB | |
| SCHEMBL13524648 | 0.77 | EPHX2 (0.58) | HSD17B1HSD17B2EPHX2IKBKBHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1545537-B1 | ALPHA-7 NICOTINIC RECEPTOR AGONISTS AND STATINS IN COMBINATION | ASTRAZENECA AB (SE) | 2007-04-04 | — | — | EP | claimed |